)
)
)
SFA Therapeutics, Inc.
SFA Therapeutics, Inc is a clinical-stage, platform-based biotech with a novel oral small molecule immunomodulatory platform based on Nobel Prize winning research in innate immunity that is focused on chronic inflammatory and autoimmune diseases with significant unmet needs. Our vision is to change Medicine.
We have compelling phase 1a and 1b data in Psoriasis showing durable response lasting years post treatment and a safety profile that has shown NO treatment emergent adverse events.
We also have compassionate use data on a patient treated with our MASH compound that has shown complete reversal of fibrosis.
In addition, we have preclinical data that shows large reduction in pancreatic cancer tumors tumor volumes never before described in the animal model. This compound was dosed in a compassionate use patient with pancreatic cancer which showed pain reduction and tumor shrinkage.
Address
JenkintownPA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)